Ignite Creation Date:
2025-12-24 @ 11:03 PM
Ignite Modification Date:
2026-02-23 @ 4:38 AM
Study NCT ID:
NCT05361369
Status:
COMPLETED
Last Update Posted:
2025-02-07
First Post:
2022-04-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioavailability Study of EVEGYN 600 mg/1000 mg/100 mg Vaginal Ovule
Sponsor:
Exeltis Turkey
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MON837.130.6
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |